DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC cut its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 7.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 50,402 shares of the medical instruments supplier’s stock after selling 3,995 shares during the period. Nisa Investment Advisors LLC’s holdings in DENTSPLY SIRONA were worth $761,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in the company. Vanguard Group Inc. lifted its position in DENTSPLY SIRONA by 0.3% during the fourth quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier’s stock worth $383,078,000 after buying an additional 65,478 shares in the last quarter. Nuance Investments LLC raised its position in DENTSPLY SIRONA by 25.0% in the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier’s stock valued at $257,103,000 after purchasing an additional 2,708,097 shares during the period. Price T Rowe Associates Inc. MD raised its position in DENTSPLY SIRONA by 18.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier’s stock valued at $238,186,000 after purchasing an additional 1,975,404 shares during the period. Fuller & Thaler Asset Management Inc. raised its position in DENTSPLY SIRONA by 2.8% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier’s stock valued at $219,018,000 after purchasing an additional 314,343 shares during the period. Finally, Lazard Asset Management LLC raised its position in DENTSPLY SIRONA by 23.0% in the fourth quarter. Lazard Asset Management LLC now owns 8,044,228 shares of the medical instruments supplier’s stock valued at $152,678,000 after purchasing an additional 1,505,928 shares during the period. 95.70% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

XRAY has been the subject of a number of research reports. Piper Sandler dropped their price objective on DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating for the company in a research note on Wednesday, April 30th. Barrington Research lifted their price objective on DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an “outperform” rating in a research note on Monday, May 12th. Wall Street Zen raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Sunday. Morgan Stanley cut DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 target price for the company. in a research note on Tuesday, April 15th. Finally, UBS Group lowered their target price on DENTSPLY SIRONA from $27.00 to $25.00 and set a “buy” rating for the company in a research note on Friday, May 9th. Eleven equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $20.36.

DENTSPLY SIRONA Trading Down 0.5%

Shares of DENTSPLY SIRONA stock opened at $15.92 on Wednesday. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.16 and a fifty-two week high of $27.95. The firm has a market cap of $3.17 billion, a PE ratio of -3.51, a P/E/G ratio of 1.14 and a beta of 0.94. The business’s fifty day moving average is $16.04 and its two-hundred day moving average is $16.34. The company has a quick ratio of 0.76, a current ratio of 1.10 and a debt-to-equity ratio of 0.79.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a positive return on equity of 14.31% and a negative net margin of 24.42%. The firm had revenue of $879.00 million during the quarter, compared to the consensus estimate of $854.75 million. During the same quarter in the previous year, the business earned $0.42 earnings per share. The firm’s quarterly revenue was down 7.8% compared to the same quarter last year. Analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, July 11th. Investors of record on Friday, June 27th were paid a $0.16 dividend. The ex-dividend date was Friday, June 27th. This represents a $0.64 dividend on an annualized basis and a yield of 4.02%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -14.10%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.